Interference with antigen processing by viruses

https://doi.org/10.1016/S0952-7915(97)80097-0Get rights and content

Abstract

Viruses that establish persistent infections in their host, such as herpesviruses, adenoviruses or HIV, express proteins designed to pre-empt or evade recognition and elimination by MHC class I restricted CD8+ T lymphocytes. Notable discoveries during the annual period of review have demonstrated that, in principle, each single step within the MHC class I pathway of antigen processing and presentation is fair game for manipulation by viral functions. The viral factors that are natural inhibitors of this pathway have been instrumental for the elucidation of the distinct molecular mechanisms that are exploited by viruses. The viral stealth strategies that downregulate MHC class I protein surface expression may lead, however, to a higher susceptibility of virus-infected cells to natural killer cell activity. Strikingly, there is evidence that some viruses counteract increased natural killer cell recognition by expressing viral MHC class I homologues that function as surrogate inhibitors of natural killer cell activity.

References (61)

  • O Schwartz et al.

    Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 nef protein

    Nat Med

    (1996)
  • ML Fahnestock et al.

    The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides

    Immunity

    (1995)
  • H Browne et al.

    Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted

    J Virol

    (1992)
  • MT Heemels et al.

    Generation, translocation, and presentation of MHC class I-restricted peptides

    Annu Rev Biochem

    (1995)
  • K Kärre

    Express yourself or die: peptides, MHC molecules, and NK cells

    Science

    (1995)
  • RG Webster et al.

    Molecular mechanisms of variation in influenza viruses

    Nature

    (1982)
  • LK Borysiewicz et al.

    Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognising the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses

    J Exp Med

    (1988)
  • MJ Gilbert et al.

    Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product

    Nature

    (1996)
  • RJ Murray et al.

    Human cytotoxic T cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses

    Proc Natl Acad Sci USA

    (1990)
  • R Khanna et al.

    Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development

    J Exp Med

    (1992)
  • F Chen et al.

    A subpopulation of normal B cells latently infected with Epstein Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1

    J Virol

    (1995)
  • J Levitskaya et al.

    Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1

    Nature

    (1995)
  • E Kieff

    Epstein—Barr virus and its replication

  • IA York et al.

    A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes

    Cell

    (1994)
  • A Hill et al.

    Herpes simplex virus turns off the TAP to evade host immunity

    Nature

    (1995)
  • K Ahn et al.

    Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47

    EMBO J

    (1996)
  • R Tomazin et al.

    Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP

    EMBO J

    (1996)
  • M Del Val et al.

    Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment

    J Exp Med

    (1992)
  • PD Barnes et al.

    Down-regulation of the class HLA heterodimer and β2-microglobulin on the surface of cells infected with cytomegalovirus

    J Gen Virol

    (1992)
  • MFC Beersma et al.

    Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains

    J Immunol

    (1993)

    • Cited by (0)

    View full text
    Copyright © 1997 Published by Elsevier Ltd.